Pseudoephedrine, PPA, nicotine therapy behind-the-counter status urged by PPSI.
This article was originally published in The Tan Sheet
Executive Summary
PSEUDOEPHEDRINE, PPA, SMOKING CESSATION AID BEHIND-THE-COUNTER PLACEMENT URGED in a recent mailing to 40,000 pharmacies by California-based Pharmacists Planning Service, Inc. (PPSI). The non-profit pharmacy education organization advised pharmacists to remove from self-service areas all pseudoephedrine and ephedrine-containing products, phenylpropanolamine (PPA) diet pills and nicotine patches and gums. These products, PPSI asserted, should "only be available with the assistance of a pharmacist or a health professional."